• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Executive Moves: Daiichi Sankyo Co.

    Valitacell, Solentim Form Biologics Collaboration

    Werum, B-EN-G Enter Partnership

    Janssen, Morphic Ink Deal Worth up to $750M

    Catalent Appoints Tech Ops SVP
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Oakrum, Aucta Form Devt. & Mfg. Partnership

    Emergex Secures State-of-the-Art R&D Facility

    WuXi Biologics Completes EMA GMP Inspection

    Achillion Expands with Launch of PA Office

    ACG Capsules Expands in Brazil
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    ACG Capsules Expands in Brazil

    Catalent Receives P&G Award

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Implementing AI in Drug Discovery

    Valitacell, Solentim Form Biologics Collaboration

    Werum, B-EN-G Enter Partnership

    Janssen, Morphic Ink Deal Worth up to $750M

    Merck to Acquire Immune Design for $300M
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    WuXi Biologics Completes EMA GMP Inspection

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Ascendia Pharmaceuticals

    Federal Equipment Company

    Jubilant HollisterStier Contract Manufacturing & Services

    Ajinomoto Bio-Pharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions, Inc.

    Ascendia Pharmaceuticals

    Jubilant HollisterStier Contract Manufacturing & Services

    Vetter Pharma International GmbH

    Emergent BioSolutions, Inc.
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    PCI Pharma Services to Acquire Sherpa Clinical Packaging

    Further expands global clinical services business

    Related CONTENT
    • PCI Bolsters Analytical Capabilities
    • PCI Launches High Containment Packaging at Ireland Site
    • Aptar Pharma, Propeller Health Enter Collaboration
    • PCI Bolsters Global Clinical Operations and Supply
    • PCI Makes Serialization Installation at UK Site
    09.11.18
    PCI Pharma Services has entered an agreement to acquire Sherpa Clinical Packaging, a provider of clinical trial material management services for clinical studies, including packaging, labeling, distribution, storage and returns and destruction services. Sherpa's facilities employ cold chain technologies that include handling products requiring labeling and kitting at frozen and refrigerated conditions.
     
    "Sherpa has always been committed to providing our customers with the best customer service and expertise in clinical supply management," said Mark Paiz, president of Sherpa. "With this acquisition, our customers will now have access to PCI's expanded clinical packaging services, extensive manufacturing of clinical trial materials, as well as global reach through U.S., European, and Asia Pacific depots to support their clinical studies."
     
    PCI provides global molecule-to-market services that span contract development and manufacturing, including specialization in highly complex and potent drugs, clinical supply services and commercial packaging services. PCI's clinical services include drug development and manufacturing, packaging and labeling, storage and logistical services, including support for Cold Chain and Ultra Cold Chain down to -196°C.  The company is strategically investing in the expansion of its global Clinical Services business and this marks its third acquisition in 12 months.
     
    "We are extremely excited for what Sherpa brings to the PCI business," said Salim Haffar, chief executive officer of PCI. "We have experienced considerable growth in our clinical business, and over the past 12 months made a number of key acquisitions to further expand our presence in key geographies including Ireland, Australia, and now California, along the way adding exciting new capabilities. Our #1 commitment to our clients is to provide the industry leading experience. This includes outstanding service, expansive capability, as well as the ability to support client studies around the world. Sherpa's tremendous growth and reputation is clearly founded in their dedication to servicing their customers at the highest levels, which very much aligns to our core mission." 
    Related Searches
    • expansion
    • packaging
    • Manufacturing
    • Clinical Packaging
    Suggested For You
    Contracting And Outsourcing Exhibitor List Contracting And Outsourcing Exhibitor List
    PCI, CSP Technologies in Exclusive Activ-Blister Alliance PCI, CSP Technologies in Exclusive Activ-Blister Alliance
    PCI Acquires Sherpa Clinical Packaging PCI Acquires Sherpa Clinical Packaging
    Sherpa Clinical Packaging Sherpa Clinical Packaging
    PCI Names Salim Haffar CEO PCI Names Salim Haffar CEO
    PCI Makes Serialization Installation at UK Site PCI Makes Serialization Installation at UK Site
    PCI Bolsters Global Clinical Operations and Supply PCI Bolsters Global Clinical Operations and Supply
    Aptar Pharma, Propeller Health Enter Collaboration Aptar Pharma, Propeller Health Enter Collaboration
    PCI Launches High Containment Packaging at Ireland Site PCI Launches High Containment Packaging at Ireland Site
    PCI Bolsters Analytical Capabilities PCI Bolsters Analytical Capabilities

    Related Breaking News

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      Valitacell, Solentim Form Biologics Collaboration

      Valitacell, Solentim Form Biologics Collaboration

      Goal is to enable earlier identification of biological candidates
      02.22.19

    • Breaking News | Promotions & Moves
      Executive Moves: Daiichi Sankyo Co.

      Executive Moves: Daiichi Sankyo Co.

      Senior-level organizational changes will oversee the company's strategic priorities
      02.22.19

    • Bio News | Collaborations & Alliances | Industry News | Information Technology
      Werum, B-EN-G Enter Partnership

      Werum, B-EN-G Enter Partnership

      PAS-X Endorsed Service Partner agreement enables B-EN-G to act as a certified service implementation team in Japan for Werum’s premier customers
      02.22.19


    • Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Preclinical Outsourcing
      Janssen, Morphic Ink Deal Worth up to $750M

      Janssen, Morphic Ink Deal Worth up to $750M

      Deal extends reach of Morphic discovery across all known human integrins
      02.22.19

    • Bio News | Industry News | Promotions & Moves
      Catalent Appoints Tech Ops SVP

      Catalent Appoints Tech Ops SVP

      Kay Schmidt has been a part of the company for nearly a decade, most recently working within the global virtual Project Management Organization unit
      02.22.19

    • Bio News | Industry News | Promotions & Moves
      BASi Announces New CCO

      BASi Announces New CCO

      Mr. Joe Flynn has over 25 years of strategic and operational experience focusing on pharmaceutical research and development
      02.22.19


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Merck to Acquire Immune Design for $300M

      Merck to Acquire Immune Design for $300M

      Bolsters capabilities in vaccine development for infectious diseases and cancer
      02.22.19

    • Bio News | Drug Discovery | Industry News | Promotions & Moves
      Sygnature Discovery Makes Key Appointments

      Sygnature Discovery Makes Key Appointments

      Dr. Allan Jordan and Ms. Louisa Jordison have joined the company as director of Oncology Drug Discovery and director of Strategic Planning, respectively
      02.22.19

    • Breaking News | Industry News
      AbbVie, Voyager Expand Parkinson

      AbbVie, Voyager Expand Parkinson's Pact

      Aims to develop and commercialize vectorized antibodies for Parkinson's that circumvent the blood-brain barrier
      02.22.19


    • Breaking News | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments
      Oakrum, Aucta Form Devt. & Mfg. Partnership

      Oakrum, Aucta Form Devt. & Mfg. Partnership

      Relates to four oral and topical generics that will hit the U.S. market
      02.22.19

    • Bio News | Collaborations & Alliances | Industry News
      ICON Acquires MolecularMD

      ICON Acquires MolecularMD

      Deal brings to ICON expanded testing platforms, including next generation sequencing, and immunohistochemistry (IHC)
      02.22.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | R&D
      Emergex Secures State-of-the-Art R&D Facility

      Emergex Secures State-of-the-Art R&D Facility

      Hires chief scientific officer to drive development of its vaccines
      02.22.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News | Inspections
      WuXi Biologics Completes EMA GMP Inspection

      WuXi Biologics Completes EMA GMP Inspection

      Becomes the first biologics company in China to do so
      02.22.19

    • Bio News | Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Methods Development | R&D
      Insilico & Teva Enter Collaboration

      Insilico & Teva Enter Collaboration

      To apply Insilico’s technology for predictive biomanufacturing to create & execute more efficient production processes of Teva’s biopharmaceutical therapeutics
      02.21.19

    • Bio News | Facilities | Industry News
      Achillion Expands with Launch of PA Office

      Achillion Expands with Launch of PA Office

      The approximately 12,000 square-feet office space will serve as Achillion’s executive offices and clinical operations base
      02.21.19

    Breaking News
    • Valitacell, Solentim Form Biologics Collaboration
    • Executive Moves: Daiichi Sankyo Co.
    • Werum, B-EN-G Enter Partnership
    • Janssen, Morphic Ink Deal Worth up to $750M
    • Catalent Appoints Tech Ops SVP
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login